Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagent
Sigma-Aldrich, Oxford BioMedica and Open Biosystems, Inc. have jointly announced a confidential settlement of their patent litigation. Sigma-Aldrich and Oxford BioMedica agreed to dismiss the lawsuit brought against Open Biosystems. Open Biosystems agreed to dismiss its counterclaims in the lawsuit. As part of the settlement Open Biosystems will acquire certain license rights under the Oxford BioMedica patents for use of the LentiVector technology in research activities. Other details of the agreement have not been disclosed.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
The Royal Swedish Academy of Sciences (RSAS) has awarded the Gregori Aminoff Prize in Crystallography 2013 - Nature of crystals measured by X-rays and interpreted in Italy and Australia
Pushing the Boundaries: New dye could open the door to in vivo applications of fluorescence anisotropy
A new tool for estimating people’s total exposure to potentially harmful chemicals is developed by Mount Sinai researchers
Thermo Fisher Scientific Strengthens Presence in India with Acquisition of Chemito Technologies
Bioelectronics: Invention of the pH imaging microscope for applications including treatment of Alzheimer’s disease.
New technique shows in detail where drug molecules hit their targets in the body - The new method could speed the development of many new drugs
Thermo Fisher Scientific and George Mason University Partner in Protein Biomarker Research Project - Collaboration Aims to Accelerate Verification and Validation of Protein Biomarkers for Earlier Disease Diagnosis and Therapeutic Efficacy
Flemish researchers provide the first experimental evidence of dynamic allostery in protein regulation
Revolutionary images of the birth of crystals - A team from the UNIGE has succeeded in visualizing crystal nucleation - the stage that precedes crystallization - that was invisible until now